China News

103 readers

1 users here now

A community for china news

founded 5 months ago

MODERATORS

rss@news.abolish.capital

Salamence@lemmy.zip

RedWizard@news.abolish.capital

Salamence@mander.xyz

Rights to antibody drug from China’s Keymed change hands in Gilead acquisition of Ouro (www.scmp.com)

submitted 1 week ago by rss@news.abolish.capital to c/china@news.abolish.capital

0 comments fedilink hide all child comments

US biopharmaceutical company Gilead Sciences agreed to buy Ouro Medicines, which is developing an antibody-based medicine for autoimmune diseases licensed from China’s Keymed Biosciences, in a deal worth up to US$2.18 billion. Gilead Sciences is among a group of global drug makers facing patent expirations and turning to mergers, acquisitions and licensing deals to refill their drug pipelines. Under the agreement, Gilead Sciences would pay shareholders of US-based Ouro Medicines US$1.675 billion...

From China - South China Morning Post via This RSS Feed.

no comments (yet)

sorted by: hot top controversial new old

there doesn't seem to be anything here